Celadon Pharmaceuticals (LSE:CEL) FCF Margin % : -41,455.56% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Celadon Pharmaceuticals's Free Cash Flow for the six months ended in Jun. 2023 was €-3.73 Mil. Celadon Pharmaceuticals's Revenue for the six months ended in Jun. 2023 was €0.01 Mil. Therefore, Celadon Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2023 was -41,455.56%.

As of today, Celadon Pharmaceuticals's current FCF Yield % is -13.00%.

The historical rank and industry rank for Celadon Pharmaceuticals's FCF Margin % or its related term are showing as below:

LSE:CEL' s FCF Margin % Range Over the Past 10 Years
Min: -217150 Med: -125383.93 Max: -33617.86
Current: -34791.67

During the past 4 years, the highest FCF Margin % of Celadon Pharmaceuticals was -33617.86%. The lowest was -217150.00%. And the median was -125383.93%.

LSE:CEL's FCF Margin % is ranked worse than
99.51% of 1025 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs LSE:CEL: -34791.67

Celadon Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Celadon Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals FCF Margin % Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Margin %

-217,150.00

-33,617.86

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial			-	-132,100.00	-37,361.54	-30,793.33	-41,455.56

Competitive Comparison of Celadon Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's FCF Margin % falls into.

Celadon Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Celadon Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-9.413	/	0.028
	=	-33,617.86 %

Celadon Pharmaceuticals's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-3.731	/	0.009
	=	-41,455.56 %

Celadon Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines